Abstract
Neuroprotective effects of new compounds directed to PP2A, a promising therapeutic target for Alzheimer’s disease.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have